Visit us at 2.A18 and discover how our regenerative solutions.

Let’s connect at our booth to discuss how Regen Lab is transforming healthcare with innovative, science-driven solutions.

Don’t miss this opportunity to network and learn at one of the premier global congresses in wound care

ESSKA Symposium

 

The Next Step in Musculoskeletal Longevity: Integrating HA, PRP, and Regenerative Matrices

At the ESSKA Congress, discover an inspiring session on the future of regenerative medicine with Dr Branko Barac, MD, PhD.

Director of the Institute of Rheumatology, Belgrade, faculty member at the University of Belgrade Faculty of Medicine, President of the Republic Regulatory Committee for Rheumatology and Regenerative Medicine, and Certified EULAR MSK Ultrasound Teacher, Dr Barac will share his expert perspective on the evolution of musculoskeletal therapies.

Through his presentation, “The Next Step in Musculoskeletal Longevity: Integrating HA, PRP, and Regenerative Matrices”, he will discuss how the combination of hyaluronic acid, PRP, and regenerative matrices is opening new possibilities for enhancing mobility, supporting joint health, and promoting musculoskeletal longevity.

A session not to be missed for healthcare professionals interested in therapeutic innovation and the future of regenerative medicine.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More